Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 2
2013 5
2014 8
2015 5
2016 7
2017 11
2018 16
2019 21
2020 19
2021 17
2022 23
2023 16
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

131 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of Integrated Outpatient Palliative Care With Standard Care in Patients With Parkinson Disease and Related Disorders: A Randomized Clinical Trial.
Kluger BM, Miyasaki J, Katz M, Galifianakis N, Hall K, Pantilat S, Khan R, Friedman C, Cernik W, Goto Y, Long J, Fairclough D, Sillau S, Kutner JS. Kluger BM, et al. Among authors: sillau s. JAMA Neurol. 2020 May 1;77(5):551-560. doi: 10.1001/jamaneurol.2019.4992. JAMA Neurol. 2020. PMID: 32040141 Free PMC article. Clinical Trial.
Mapping sleep's oscillatory events as a biomarker of Alzheimer's disease.
Pulver RL, Kronberg E, Medenblik LM, Kheyfets VO, Ramos AR, Holtzman DM, Morris JC, Toedebusch CD, Sillau SH, Bettcher BM, Lucey BP, McConnell BV. Pulver RL, et al. Among authors: sillau sh. Alzheimers Dement. 2024 Jan;20(1):301-315. doi: 10.1002/alz.13420. Epub 2023 Aug 23. Alzheimers Dement. 2024. PMID: 37610059 Free PMC article.
Cognitive Safety Data from a Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase IIb Study of the Effects of a Cannabidiol and Δ9-Tetrahydrocannabinol Drug on Parkinson's Disease-Related Motor Symptoms.
Domen CH, Sillau S, Liu Y, Adkins M, Rajkovic S, Bainbridge J, Sempio C, Klawitter J, Leehey MA. Domen CH, et al. Among authors: sillau s. Mov Disord. 2023 Jul;38(7):1341-1346. doi: 10.1002/mds.29447. Epub 2023 May 22. Mov Disord. 2023. PMID: 37212386 Clinical Trial.
Disease Progression in Charcot-Marie-Tooth Disease Related to MPZ Mutations: A Longitudinal Study.
Fridman V, Sillau S, Bockhorst J, Smith K, Moroni I, Pagliano E, Pisciotta C, Piscosquito G, Laurá M, Muntoni F, Bacon C, Feely S, Grider T, Gutmann L, Shy R, Wilcox J, Herrmann DN, Li J, Ramchandren S, Sumner CJ, Lloyd TE, Day J, Siskind CE, Yum SW, Sadjadi R, Finkel RS, Scherer SS, Pareyson D, Reilly MM, Shy ME; Inherited Neuropathies Consortium-Rare Diseases Clinical Research Network. Fridman V, et al. Among authors: sillau s. Ann Neurol. 2023 Mar;93(3):563-576. doi: 10.1002/ana.26518. Epub 2022 Oct 28. Ann Neurol. 2023. PMID: 36203352 Free PMC article.
Safety and patient experience with at-home infusion of ocrelizumab for multiple sclerosis.
Barrera B, Simpson H, Engebretson E, Sillau S, Valdez B, Parra-González J, Winger RC, Epperson LA, Banks A, Pierce K, Spotts M, O'Gean K, Alvarez E, Gross R, Piquet AL, Schreiner T, Corboy JR, Pei J, Vollmer TL, Nair KV. Barrera B, et al. Among authors: sillau s. Ann Clin Transl Neurol. 2023 Apr;10(4):579-588. doi: 10.1002/acn3.51745. Epub 2023 Feb 22. Ann Clin Transl Neurol. 2023. PMID: 36811392 Free PMC article. Clinical Trial.
The global prevalence of human fascioliasis: a systematic review and meta-analysis.
Rosas-Hostos Infantes LR, Paredes Yataco GA, Ortiz-Martínez Y, Mayer T, Terashima A, Franco-Paredes C, Gonzalez-Diaz E, Rodriguez-Morales AJ, Bonilla-Aldana DK, Vargas Barahona L, Grimshaw AA, Chastain DB, Sillau S, Marcos LA, Henao-Martínez AF. Rosas-Hostos Infantes LR, et al. Among authors: sillau s. Ther Adv Infect Dis. 2023 Jul 8;10:20499361231185413. doi: 10.1177/20499361231185413. eCollection 2023 Jan-Dec. Ther Adv Infect Dis. 2023. PMID: 37434654 Free PMC article.
SARS-CoV-2 mRNA vaccination induces an antigen-specific T cell response correlating with plasma interferon-gamma in B cell depleted patients.
Borko TL, Baxter R, Cabrera-Martinez B, Thiruppathi E, Sabalza M, Venkataraman I, Selva S, Rester C, Sillau S, Pastula DM, Bennett JL, Alvarez E, Gross R, Shah A, Kammeyer R, Corboy JR, Kedl RM, Hsieh EWY, Piquet AL. Borko TL, et al. Among authors: sillau s. J Neuroimmunol. 2023 Oct 15;383:578192. doi: 10.1016/j.jneuroim.2023.578192. Epub 2023 Aug 29. J Neuroimmunol. 2023. PMID: 37666038 Free PMC article.
Aberrant Immunoglobulin G Glycosylation in Multiple Sclerosis.
Kennedy PGE, Graner M, Pointon T, Li X, Tanimoto K, Dennison K, Im G, Fringuello A, Zhou W, Graner A, Sillau S, Vollmer T, Yu X. Kennedy PGE, et al. Among authors: sillau s. J Neuroimmune Pharmacol. 2022 Jun;17(1-2):218-227. doi: 10.1007/s11481-021-09996-1. Epub 2021 May 3. J Neuroimmune Pharmacol. 2022. PMID: 33942224 Free PMC article.
131 results